Jeffrey Laux
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jeffrey Laux has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Scott Tho Vasher
Division of Pulmonary and Critical Care Medicine, University of North Carolina, Chapel Hill, NC, United States
2 shared publications - Angela Wabulya
University of North Carolina at Chapel Hill
1 shared publication - Anil K. Gehi
University of North Carolina at Chapel Hill
1 shared publication - Anthony J. Mazzella
University of North Carolina at Chapel Hill
1 shared publication Ari Becker
Department of Medicine, Division of Cardiology, University of North Carolina at Chapel Hill (A.G., T.A., J.W., L.R., A.B., O.A., A.J.M.).
1 shared publicationBasil Mathews
Department of Ophthalmology, Kittner Eye Center at University of North Carolina, 2226 Nelson Highway, Chapel Hill, NC, USA
1 shared publication
Latest Publications
- Open Access
Change in Resting-State functional MRI Connectivity to Measure Individual Response to Epilepsy Surgery
Objective: This study evaluates fractional power spectrum contribution (fPSC), a biomarker derived from resting-state functional MRI (rs-fMRI), as an indicator of epileptogenic network activity in drug-resistant epilepsy (DRE) patients undergoing surgery. We aimed to assess pre-to post-operative changes in fPSC and their correlation with seizure outcomes. Methods: A retrospective cohort of 56 pediatric DRE patients with pre- and post-operative rs-fMRI were evaluated. Independent component analysis (ICA) was applied to identify resting-state networks (RSNs). Each ICA RSN’s power spectrum within the range of 0.06–0.25 Hz was quantified by fPSC. The change in this fPSC was compared pre- and post-operatively using paired t-tests. Multivariate analyses including correlations with clinical outcomes were evaluated by linear mixed effects models and ANOVA. Results: Among the 56 patients, 80.4% demonstrated greater than 50% seizure reduction post-surgery, with 64.3% achieving seizure freedom. fPSC significantly decreased after surgery (t=3.0, p=0.005), indicating a reduction in epileptogenic network activity. The mixed effects model, controlling for covariates, also showed a significant effect of post-surgical scan on fPSC reduction (χ ² =8.4, df=1, p=0.004). However, there was insufficient evidence to establish an association between changes in fPSC and clinical improvement score (p=0.16) or seizure frequency (p=0.49). Conclusion: The observed reduction in fPSC post-surgery highlights its potential as a biomarker of atypical network activity in epilepsy, offering a network-specific, whole-brain approach independent of anatomical coordinates. However, its lack of correlation with clinical outcomes underscores the need for further refinement and validation to establish fPSC as a reliable measure of epileptogenic burden. HIGHLIGHTS: fPSC analysis using rs-fMRI detects a moderate treatment effect of epilepsy surgery, independent of relative network volume changes. fPSC analysis provides a method to quantify whole-brain network dysfunction in epilepsy without the need for a seizure onset zone identification-hypothesis. A trend towards direct correlation is observed between fPSC post-operative change and seizure outcomes in epilepsy surgery.
Open AccessChange in Resting-State functional MRI Connectivity to Measure Individual Response to Epilepsy Surgery
Objective: This study evaluates fractional power spectrum contribution (fPSC), a biomarker derived from resting-state functional MRI (rs-fMRI), as an indicator of epileptogenic network activity in drug-resistant epilepsy (DRE) patients undergoing surgery. We aimed to assess pre-to post-operative changes in fPSC and their correlation with seizure outcomes. Methods: A retrospective cohort of 56 pediatric DRE patients with pre- and post-operative rs-fMRI were evaluated. Independent component analysis (ICA) was applied to identify resting-state networks (RSNs). Each ICA RSN’s power spectrum within the range of 0.06–0.25 Hz was quantified by fPSC. The change in this fPSC was compared pre- and post-operatively using paired t-tests. Multivariate analyses including correlations with clinical outcomes were evaluated by linear mixed effects models and ANOVA. Results: Among the 56 patients, 80.4% demonstrated greater than 50% seizure reduction post-surgery, with 64.3% achieving seizure freedom. fPSC significantly decreased after surgery (t=3.0, p=0.005), indicating a reduction in epileptogenic network activity. The mixed effects model, controlling for covariates, also showed a significant effect of post-surgical scan on fPSC reduction (χ ² =8.4, df=1, p=0.004). However, there was insufficient evidence to establish an association between changes in fPSC and clinical improvement score (p=0.16) or seizure frequency (p=0.49). Conclusion: The observed reduction in fPSC post-surgery highlights its potential as a biomarker of atypical network activity in epilepsy, offering a network-specific, whole-brain approach independent of anatomical coordinates. However, its lack of correlation with clinical outcomes underscores the need for further refinement and validation to establish fPSC as a reliable measure of epileptogenic burden. HIGHLIGHTS: fPSC analysis using rs-fMRI detects a moderate treatment effect of epilepsy surgery, independent of relative network volume changes. fPSC analysis provides a method to quantify whole-brain network dysfunction in epilepsy without the need for a seizure onset zone identification-hypothesis. A trend towards direct correlation is observed between fPSC post-operative change and seizure outcomes in epilepsy surgery.
- Open Access
- 7 August 2024
- Published by Elsevier in CHEST Critical Care
- Vol. 2 (4)
Predictors of Medical Mistrust Among Surrogate Decision-Makers of Patients in the ICU at High Risk of Death
- 7 August 2024
- Published by Elsevier in CHEST Critical Care
- Vol. 2 (4)
Open AccessPredictors of Medical Mistrust Among Surrogate Decision-Makers of Patients in the ICU at High Risk of Death
- Open Access
- 7 September 2023
- Published by Wolters Kluwer Health in Journal of Continuing Education in the Health Professions
- Vol. 44 (2) , 90-96
Evaluating Leadership Development Competencies of Clinicians to Build Health Equity in America
Introduction: To achieve more equitable health, health care must be grounded in an understanding of social determinants of health. Clinicians need hands-on, equity-centered training in interdisciplinary settings where they can further develop leadership skills and apply learnings in real-time. The Clinical Scholars program trained five cohorts of health care professionals in 25 leadership development competencies to contribute toward advancing health equity within the organizations and communities where they work. This study describes the self-reported ratings of three dimensions of competencies within four domains. Methods: Data from 169 Fellows were collected at three time-points during the three-year training program using Qualtrics and Research Electronic Data Captrue software. Analysis was conducted in R and included descriptive statistics, fitting a linear mixed-effects model using random intercepts, and paired-sample t tests to assess significance between baseline and endpoint ratings. Results: We found improved ratings over time for each of the three competency dimensions (knowledge, self-efficacy, use) and significant differences in ratings from baseline to endpoint, by domain (personal, interpersonal, organizational, community, and systems). Discussion: These findings support the effectiveness of an equity-centered leadership development curriculum in training health care professionals to address health challenges in their communities and organizations, thereby furthering the broader goal of achieving more equitable health for all.
- 7 September 2023
- Published by Wolters Kluwer Health in Journal of Continuing Education in the Health Professions
- Vol. 44 (2) , 90-96
Open AccessEvaluating Leadership Development Competencies of Clinicians to Build Health Equity in America
Introduction: To achieve more equitable health, health care must be grounded in an understanding of social determinants of health. Clinicians need hands-on, equity-centered training in interdisciplinary settings where they can further develop leadership skills and apply learnings in real-time. The Clinical Scholars program trained five cohorts of health care professionals in 25 leadership development competencies to contribute toward advancing health equity within the organizations and communities where they work. This study describes the self-reported ratings of three dimensions of competencies within four domains. Methods: Data from 169 Fellows were collected at three time-points during the three-year training program using Qualtrics and Research Electronic Data Captrue software. Analysis was conducted in R and included descriptive statistics, fitting a linear mixed-effects model using random intercepts, and paired-sample t tests to assess significance between baseline and endpoint ratings. Results: We found improved ratings over time for each of the three competency dimensions (knowledge, self-efficacy, use) and significant differences in ratings from baseline to endpoint, by domain (personal, interpersonal, organizational, community, and systems). Discussion: These findings support the effectiveness of an equity-centered leadership development curriculum in training health care professionals to address health challenges in their communities and organizations, thereby furthering the broader goal of achieving more equitable health for all.
- 1 September 2023
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 16 (9) , e009808
Implementation of an Atrial Fibrillation Decision Aid Care Pathway in the Emergency Department Reduces Atrial Fibrillation Hospitalizations
BACKGROUND: A straightforward decision aid to guide disposition of atrial fibrillation (AF) patients in the emergency department (ED) was developed for use by ED providers. The implementation of this decision aid in the ED has not been studied. METHODS: A pragmatic stepped-wedge cluster approach for analysis of retrospectively collected electronic health record data was used in which 5 hospitals were selected to commence the intervention at periodic intervals following an initial 1-year baseline assessment with 5 additional hospitals included in the comparison group (all in North Carolina). The primary end point of analysis was hospitalization rate. Hierarchical multivariable logistic regression analyses for admission as a function of the intervention while controlling for prespecified patient and hospital predictors were performed with clustering done at the hospital level. RESULTS: Between October 2017 and May 2020, a total of 11 458 patients (mean age, 71.4; 50.5% female) presented to 1 of the 10 hospitals with a primary diagnosis of AF. Absolute admission rate was reduced from 60.5% to 48.3% following the intervention (odds ratio, 0.83 [95% CI, 0.71–0.97]; P =0.016). After adjusting for covariates, the intervention was associated with a small increased rate of return to the ED for AF within 30 days of the initial presentation (1.6% to 2.7%; hazard ratio, 1.70 [95% CI, 1.26–2.31]; P <0.001). CONCLUSIONS: We demonstrate that implementation of a novel decision aid to guide disposition of patients primary diagnosis of AF presenting to the ED was associated with a reduced admission rate independent of patient and hospital factors. Use of the protocol was associated with a small but significant increase in rate of repeat presentations for AF at 30-day follow-up. Use of a decision aid such as the one described here represents an important tool to reduce unnecessary AF hospitalizations.
- 1 September 2023
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 16 (9) , e009808
Implementation of an Atrial Fibrillation Decision Aid Care Pathway in the Emergency Department Reduces Atrial Fibrillation Hospitalizations
BACKGROUND: A straightforward decision aid to guide disposition of atrial fibrillation (AF) patients in the emergency department (ED) was developed for use by ED providers. The implementation of this decision aid in the ED has not been studied. METHODS: A pragmatic stepped-wedge cluster approach for analysis of retrospectively collected electronic health record data was used in which 5 hospitals were selected to commence the intervention at periodic intervals following an initial 1-year baseline assessment with 5 additional hospitals included in the comparison group (all in North Carolina). The primary end point of analysis was hospitalization rate. Hierarchical multivariable logistic regression analyses for admission as a function of the intervention while controlling for prespecified patient and hospital predictors were performed with clustering done at the hospital level. RESULTS: Between October 2017 and May 2020, a total of 11 458 patients (mean age, 71.4; 50.5% female) presented to 1 of the 10 hospitals with a primary diagnosis of AF. Absolute admission rate was reduced from 60.5% to 48.3% following the intervention (odds ratio, 0.83 [95% CI, 0.71–0.97]; P =0.016). After adjusting for covariates, the intervention was associated with a small increased rate of return to the ED for AF within 30 days of the initial presentation (1.6% to 2.7%; hazard ratio, 1.70 [95% CI, 1.26–2.31]; P <0.001). CONCLUSIONS: We demonstrate that implementation of a novel decision aid to guide disposition of patients primary diagnosis of AF presenting to the ED was associated with a reduced admission rate independent of patient and hospital factors. Use of the protocol was associated with a small but significant increase in rate of repeat presentations for AF at 30-day follow-up. Use of a decision aid such as the one described here represents an important tool to reduce unnecessary AF hospitalizations.
- Open Access
- 3 February 2022
- Published by Wiley in Journal of Ophthalmology
- Vol. 2022, 1-7
Comparison of ZETA Fast (PTS) (Optopol Technology) and Humphrey SITA Fast (SFA) (Carl Zeiss Meditec) Perimetric Strategies
Purpose. To compare two threshold strategies for visual field assessment, ZETA Fast (Optopol Technology) and Humphrey SITA Fast (Carl Zeiss Meditec), in controls and subjects with glaucoma. Patients and Methods. A prospective case-control study was carried out in which the clinical practice study included 26 controls and 26 glaucoma subjects. Testing for each strategy was monocular. Quantitative comparisons of mean deviation (MD), pattern standard deviation (PSD), visual field index (VFI), and test duration were made using two one-sided t-tests and Wilcoxon signed-rank tests. Confusion matrices were constructed to assess Optopol’s detection as a proxy for Zeiss’s detection of early glaucomatous defects. Receiver operating characteristic (ROC) curves were used to assess MD and PSD’s discriminability. Results. The difference in MD values (Optopol-Zeiss) was within the margin for controls (difference = 0.36, ), but not for glaucomatous subjects (difference = 2.16, ). The Optopol strategy took longer than the Zeiss strategy in both controls (difference = 23 seconds, ) and glaucomatous subjects (difference = 49 seconds, ). PSD values were higher and VFI values were lower from Optopol in glaucomatous subjects ( and ). Optopol was 92% sensitive in capturing early glaucomatous defects with MD <−2 when compared to Zeiss ( ). ROC analysis shows Optopol yields higher discriminability than Zeiss for MD/PSD indices. Conclusions. Both strategies enable effective identification of glaucomatous defects within 6 minutes; they also offer high sensitivity with a high correlation in global indices between the two strategies. The Optopol strategy is an alternative to the Zeiss counterpart with the limitation of a marginally longer testing protocol but a higher sensitivity of detecting glaucomatous defects.
- 3 February 2022
- Published by Wiley in Journal of Ophthalmology
- Vol. 2022, 1-7
Open AccessComparison of ZETA Fast (PTS) (Optopol Technology) and Humphrey SITA Fast (SFA) (Carl Zeiss Meditec) Perimetric Strategies
Purpose. To compare two threshold strategies for visual field assessment, ZETA Fast (Optopol Technology) and Humphrey SITA Fast (Carl Zeiss Meditec), in controls and subjects with glaucoma. Patients and Methods. A prospective case-control study was carried out in which the clinical practice study included 26 controls and 26 glaucoma subjects. Testing for each strategy was monocular. Quantitative comparisons of mean deviation (MD), pattern standard deviation (PSD), visual field index (VFI), and test duration were made using two one-sided t-tests and Wilcoxon signed-rank tests. Confusion matrices were constructed to assess Optopol’s detection as a proxy for Zeiss’s detection of early glaucomatous defects. Receiver operating characteristic (ROC) curves were used to assess MD and PSD’s discriminability. Results. The difference in MD values (Optopol-Zeiss) was within the margin for controls (difference = 0.36, ), but not for glaucomatous subjects (difference = 2.16, ). The Optopol strategy took longer than the Zeiss strategy in both controls (difference = 23 seconds, ) and glaucomatous subjects (difference = 49 seconds, ). PSD values were higher and VFI values were lower from Optopol in glaucomatous subjects ( and ). Optopol was 92% sensitive in capturing early glaucomatous defects with MD <−2 when compared to Zeiss ( ). ROC analysis shows Optopol yields higher discriminability than Zeiss for MD/PSD indices. Conclusions. Both strategies enable effective identification of glaucomatous defects within 6 minutes; they also offer high sensitivity with a high correlation in global indices between the two strategies. The Optopol strategy is an alternative to the Zeiss counterpart with the limitation of a marginally longer testing protocol but a higher sensitivity of detecting glaucomatous defects.
- Open Access
- 1 December 2013
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 51 (12) , 4126-4129
Clinical Outcomes with Rapid Detection of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Isolates from Routine Blood Cultures
Staphylococcus aureus is a common cause of bacteremia, with a substantial impact on morbidity and mortality. Because of increasing rates of methicillin-resistant Staphylococcus aureus , vancomycin has become the standard empirical therapy. However, beta-lactam antibiotics remain the best treatment choice for methicillin-susceptible strains. Placing patients quickly on the optimal therapy is one goal of antimicrobial stewardship. This retrospective, observational, single-center study compared 33 control patients utilizing only traditional full-susceptibility methodology to 22 case patients utilizing rapid methodology with CHROMagar medium to detect and differentiate methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains hours before full susceptibilities were reported. The time to targeted therapy was statistically significantly different between control patients (mean, 56.5 ± 13.6 h) and case patients (44.3 ± 17.9 h) ( P = 0.006). Intensive care unit status, time of day results emerged, and patient age did not make a difference in time to targeted therapy, either singly or in combination. Neither length of stay ( P = 0.61) nor survival ( P = 1.0) was statistically significantly different. Rapid testing yielded a significant result, with a difference of 12.2 h to targeted therapy. However, there is still room for improvement, as the difference in time to susceptibility test result between the full traditional methodology and CHROMagar was even larger (26.5 h). This study supports the hypothesis that rapid testing plays a role in antimicrobial stewardship by getting patients on targeted therapy faster.
- 1 December 2013
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 51 (12) , 4126-4129
Open AccessClinical Outcomes with Rapid Detection of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Isolates from Routine Blood Cultures
Staphylococcus aureus is a common cause of bacteremia, with a substantial impact on morbidity and mortality. Because of increasing rates of methicillin-resistant Staphylococcus aureus , vancomycin has become the standard empirical therapy. However, beta-lactam antibiotics remain the best treatment choice for methicillin-susceptible strains. Placing patients quickly on the optimal therapy is one goal of antimicrobial stewardship. This retrospective, observational, single-center study compared 33 control patients utilizing only traditional full-susceptibility methodology to 22 case patients utilizing rapid methodology with CHROMagar medium to detect and differentiate methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains hours before full susceptibilities were reported. The time to targeted therapy was statistically significantly different between control patients (mean, 56.5 ± 13.6 h) and case patients (44.3 ± 17.9 h) ( P = 0.006). Intensive care unit status, time of day results emerged, and patient age did not make a difference in time to targeted therapy, either singly or in combination. Neither length of stay ( P = 0.61) nor survival ( P = 1.0) was statistically significantly different. Rapid testing yielded a significant result, with a difference of 12.2 h to targeted therapy. However, there is still room for improvement, as the difference in time to susceptibility test result between the full traditional methodology and CHROMagar was even larger (26.5 h). This study supports the hypothesis that rapid testing plays a role in antimicrobial stewardship by getting patients on targeted therapy faster.